M4MM
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
Helus Pharma Teams Up with TARA Mind on Veteran Mental Health Efforts
NEW YORK – Helus Pharma, a clinical-stage biopharmaceutical company focused on developing novel serotonergic agonists (NSAs) to treat mental health conditions, announced it has joined forces with TARA Mind to help recruit veterans for its ...
Rescheduling: What it Actually Means for US Cannabis
LOS ANGELES – For years, the Cannabis industry's most reliable tradition has been misreading federal signals. When the DEA floated rescheduling proposals, operators popped champagne. When states passed adult-use laws, investors rushed in ahead of ...
DEA Opens Federal Registration Portal for Medical Cannabis Dispensaries
WASHINGTON – The Drug Enforcement Administration (DEA) is set to launch its new online portal on Wednesday, 29 April at 9:00 AM EST, facilitating the application process for state-licensed medical Cannabis dispensaries seeking federal registration ...
Blind Spot: Cannabis Industry Falls Short on Communications
NEW YORK – Legal Cannabis brought in $38.5 billion in revenue in 2024. Whitney Economics estimated that figure to drop to between $29.1 billion and $29.6 billion in 2025, due to falling prices, tax pressures, ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
Verano Raises Credit Limit to $100M, Extending Repayment Deadline to 2029
CHICAGO – Verano Holdings Corp. disclosed an update to its revolving credit facility that lifts the available funds to $100 million and stretches the repayment deadline. The change adds $25 million to the prior $75 ...
Circle K Tests Hemp THC Waters in Texas
DALLAS – Circle K has begun stocking shelves with hemp-derived THC beverages at select Texas stores, marking the c-store chain's first foray into the state's market for intoxicating hemp products. The rollout, in partnership with ...
Is the Movement to Repeal Adult-Use Cannabis in Three States a Real Threat to Their Budgets?
NEW YORK – In a development that has raised eyebrows among industry watchers, advocacy groups in Massachusetts, Maine, and Arizona are pushing ballot measures to dismantle key elements of adult-use Cannabis programs, even as these ...
Indiana Residents Voice Strong Support for Medical and Recreational Cannabis Legalization
INDIANAPOLIS – A recent survey of Hoosier voters indicates broad agreement on expanding access to Cannabis, with 84% in favor of medical use and 59% supporting recreational legalization. The findings, drawn from the 2025 Hoosier ...
Bipartisan Bill Aims to Push Back Hemp Ban for Two Years
WASHINGTON – A group of lawmakers from both parties filed legislation seeking to push back a forthcoming federal prohibition on certain hemp-derived products until late 2028, offering the industry a brief reprieve to adjust operations. ...
U.S. Legal Cannabis Sales Hit $2.3B in December, Lifting 2025 Total to $27B
LOS ANGELES – Legal Cannabis sales across the United States reached $2.3 billion in December, pushing the full-year figure for 2025 to $27 billion. The month’s tally edged out November’s $2.2 billion and aligned closely ...
California DCC Grants $1.8M to UC Berkeley and Glass House Brands for Cannabis Yield Study
LONG BEACH – State regulators have awarded $1.8 million to a partnership between the University of California Berkeley and Glass House Brands to study variations in Cannabis crop yields across cultivation methods, a move that ...
MindMed Rebrands as Definium Therapeutics, Targets 2026 Trials for LSD-Based Treatments
NEW YORK – Mind Medicine (MindMed) Inc., a developer of treatments derived from psychedelics for mental health conditions, has changed its name to Definium Therapeutics Inc., a move that underscores its push into late-stage testing ...
Sunderstorm Welcomes Lime to Its Family of Brands
LOS ANGELES – Sunderstorm, the California-based Cannabis company behind the popular Kanha edibles line, revealed its purchase of Lime, an expert in pre-rolled joints that has carved out a steady presence in the state's retail ...
Curaleaf Observes Delaware Base to Tighten U.S. Footprint
DOVER – Curaleaf Holdings Inc. has filed for shareholder approval to relocate its corporate domicile from British Columbia, Canada, to Delaware, a change designed to match its heavy concentration of business in the American market. ...
Tilray Brands Reports Q2 Fiscal 2026 Financial Results
NEW YORK – Tilray Brands Inc. posted net revenue of $217.5 million for its fiscal second quarter ended November 30, 2025, marking the company's highest quarterly figure to date and edging up 3% from $211 ...
Helus Pharma Rings Nasdaq Bell Post-Cybin Rebrand
TORONTO – Helus Pharma Inc., rebranded from Cybin Inc., opened trading on the Nasdaq Global Market under the ticker symbol $HELP, marking a shift from the NYSE American where it previously traded as $CYBN. The ...
Who Will Decide Cannabis Legalization? The Math Will.
LOS ANGELES -For decades, Cannabis reform in the United States has moved unevenly—state by state, ballot by ballot, crisis by crisis. On paper, federal prohibition still stands, and national politics remain polarized. But economically and ...
Canopy Growth Locks in Debt Overhaul, Gears Up for Expansion
TORONTO – Canopy Growth Corp. detailed a pair of financial maneuvers aimed at shoring up its books and clearing a path for expansion. The deals, which include a new $150 million U.S. term loan and ...
U.S. Hempcrete Market Set for Steady Rise to $10.6B by 2033
LOS ANGELES – The market for hempcrete, a lightweight composite material derived from the woody core of the hemp plant, stands at $7.83 billion this year and could reach $10.6 billion by 2033. That trajectory ...
